Edition:
India

Lupin Ltd (LUPN.NS)

LUPN.NS on National Stock Exchange of India

836.75INR
14 Aug 2018
Change (% chg)

Rs24.80 (+3.05%)
Prev Close
Rs811.95
Open
Rs815.00
Day's High
Rs840.00
Day's Low
Rs807.55
Volume
3,243,237
Avg. Vol
2,724,839
52-wk High
Rs1,090.00
52-wk Low
Rs723.65

Select another date:

Wed, Aug 8 2018

Photo

India's Lupin first-quarter profit misses estimate by wide margin

Drugmaker Lupin Ltd posted a bigger-than-expected fall in first-quarter profit on Wednesday, hurt by declining sales in the United States and Japan.

UPDATE 1-India's Lupin Q1 profit misses estimate by wide margin

Aug 8 Drugmaker Lupin Ltd posted a bigger-than-expected fall in first-quarter profit on Wednesday, hurt by declining sales in the United States and Japan.

India's Lupin quarterly profit falls 43 pct

Aug 8 Drugmaker Lupin Ltd posted a 43 percent fall in first-quarter profit on Wednesday, widely missing analysts' estimates.

BUZZ-Weak Q1 expected for Cadila, Lupin; improving trends for Cipla, Sun - Credit Suisse

** April-June quarter should be weak for Cadila Healthcare Ltd and Lupin Ltd with sharp declines in U.S. sales q-o-q - Credit Suisse (CS)

Lupin expects U.S. drug pricing pressure to ease in 2019

India's second-largest drugmaker Lupin Ltd said on Wednesday it expected pressure on drug prices in the United States, which has hit its profits, to ease this year as larger rivals reduce their exposure there.

UPDATE 2-India's Lupin expects U.S. drug pricing pressure to ease in 2019

* U.S. sales fall 21.1 pct; India sales up 14 pct (Adds management comments from conference call)

India's Lupin posts surprise Q4 loss on one-time charge

May 15 Lupin Ltd, India's second-largest drugmaker by revenue, reported a surprise loss in its fiscal fourth quarter on Tuesday, due to a one-time charge.

BRIEF-India's Lupin Posts March Quarter Consol Net Loss

* MARCH QUARTER CONSOL NET LOSS 7.84 BILLION RUPEES VERSUS PROFIT OF 3.80 BILLION RUPEES LAST YEAR

BRIEF-Lupin Launches Corcal Bone And Beauty Supplement

* LAUNCHES CORCAL BONE AND BEAUTY SUPPLEMENT Source text: http://bit.ly/2I8514t Further company coverage:

BRIEF-Lupin Submits New Drug Application For Etanercept Biosimilar In Japan

* SAYS SUBMITS NEW DRUG APPLICATION FOR ETANERCEPT BIOSIMILAR IN JAPAN

Select another date: